[Prevalence, characteristics and clinical correlates of left ventricular hypertrophy in stable hypertension.

Giornale Italiano Di Cardiologia
|March 1, 1987
PubMed

Insights

Left ventricular hypertrophy (LVH) affects nearly 73% of stable hypertensives, with concentric and eccentric patterns observed. Age, not BMI or hypertension severity, correlates with LVH patterns.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Medical Imaging

Context:

  • Hypertension is a prevalent condition associated with cardiovascular complications.
  • Left ventricular hypertrophy (LVH) is a common adaptation to chronic hypertension.
  • Understanding the prevalence and patterns of LVH is crucial for risk stratification.

Purpose:

  • To evaluate the prevalence and patterns of left ventricular hypertrophy (LVH) in stable hypertensive patients.
  • To identify clinical correlates of different LVH patterns using echocardiography.
  • To investigate the relationship between demographic and clinical factors and LVH morphology.

Summary:

  • Echocardiography revealed LVH in 73% of 251 stable hypertensive patients.
  • Concentric LVH (39.4%) and eccentric LVH (43.1%) were the predominant patterns.
  • Older age was associated with concentric LVH, while BMI, hypertension duration, and severity showed poor correlation with LVH patterns.

Impact:

  • Findings suggest that age is a significant factor in LVH development, challenging previous hypotheses on pattern progression.
  • The study highlights the need for further research into distinct hemodynamic profiles associated with concentric versus eccentric LVH.
  • Results contribute to a better understanding of hypertensive heart disease and potential therapeutic targets.

Related Concept Videos

Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...